European equities traded in the US as American depositary receipts were tracking lower late Thursday morning, declining 1.22% to 1,824.99 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by brewing company Anheuser-Busch InBev (BUD) and internet advertising firm Criteo (CRTO), which rose 4.6% and 2.5% respectively. They were followed by biopharmaceutical company argenx (ARGX) and pharmaceutical company Novo Nordisk (NVO), which were up 1.3% and 0.7% respectively.

The decliners from continental Europe were led by telecommunications company Nokia (NOK) and pharmaceutical company Sanofi (SNY), which fell 5.2% and 4% respectively. They were followed by internet browser company Opera (OPRA) and biotech firm Evaxion (EVAX), which were down 3.7% and 3.1% respectively.

From the UK and Ireland, the gainers were led by hospitality company InterContinental Hotels Group (IHG) and educational publisher Pearson (PSO), which advanced 1.9% and 0.9% respectively. They were followed by medical device maker Smith & Nephew (SNN) and pharmaceutical company Silence Therapeutics (SLN), which increased 0.6% and 0.1% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies Biodexa Pharmaceuticals (BDRX) and Mereo BioPharma Group (MREO), which dropped 9.1% and 8.3% respectively. They were followed by insurance company Prudential (PUK) and biopharmaceutical company and Akari Therapeutics (AKTX), which lost 7.6% and 2.3% respectively.